CMS enters drug price negotiation arena in sea change for industry
Clarivate
AUGUST 20, 2024
Although the reported negotiated prices may ignore the real-world role of contracting by manufacturers and private payers over formulary placement, the reported prices nonetheless are likely to have downstream impacts on how private payers reimburse these therapies and their competitors. These ten drugs cost Medicare Part D nearly $46.8
52 
Let's personalize your content